中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
28期
7-9,10
,共4页
李小兵%熊勇%邹瑜斌%徐满珍
李小兵%熊勇%鄒瑜斌%徐滿珍
리소병%웅용%추유빈%서만진
结直肠癌%血小板%淋巴细胞%5年存活率
結直腸癌%血小闆%淋巴細胞%5年存活率
결직장암%혈소판%림파세포%5년존활솔
Colorectal cancer%Platelets%Lymphocytes%Five-year survival rate
目的:讨论术前血小板/淋巴细胞比值(PLR)对结直肠癌患者预后的影响。方法:选取2007年6月-2012年6月本院收治的150例结直肠癌患者作为研究对象,根据手术前、后常规血液检查结果,计算PLR。按照PLR是否<250,将患者分为高值组(PLR≥250)28例和低值组(PLR<250)122例。观察比较两组患者的一般资料、不同TNM分期和不同分化程度的5年存活率,以探讨PLR对结直肠癌患者预后的影响。结果:高值组结肠癌患者比例67.86%(19/28)明显高于低值组的45.90%(56/122),接受腹腔镜手术比例14.29%(4/28)明显低于低值组的40.16%(49/122),低值组的5年生存率77.05%(94/122)明显高于高值组的50.00%(14/28),且高值组晚期患者(Ⅲ、Ⅳ期)和分化差患者(差及黏液性患者)的5年生存率分别为28.57%(4/14)和40.00%(4/10),均明显低于低值组的62.90%(39/62)和75.00%(27/36),差异均有统计学意义(P<0.05)。结论:高PLR值结直肠癌患者的5年存活率显著低于低PLR值患者。PLR是判断结直肠癌患者预后情况的重要指标,值得在临床中运用。
目的:討論術前血小闆/淋巴細胞比值(PLR)對結直腸癌患者預後的影響。方法:選取2007年6月-2012年6月本院收治的150例結直腸癌患者作為研究對象,根據手術前、後常規血液檢查結果,計算PLR。按照PLR是否<250,將患者分為高值組(PLR≥250)28例和低值組(PLR<250)122例。觀察比較兩組患者的一般資料、不同TNM分期和不同分化程度的5年存活率,以探討PLR對結直腸癌患者預後的影響。結果:高值組結腸癌患者比例67.86%(19/28)明顯高于低值組的45.90%(56/122),接受腹腔鏡手術比例14.29%(4/28)明顯低于低值組的40.16%(49/122),低值組的5年生存率77.05%(94/122)明顯高于高值組的50.00%(14/28),且高值組晚期患者(Ⅲ、Ⅳ期)和分化差患者(差及黏液性患者)的5年生存率分彆為28.57%(4/14)和40.00%(4/10),均明顯低于低值組的62.90%(39/62)和75.00%(27/36),差異均有統計學意義(P<0.05)。結論:高PLR值結直腸癌患者的5年存活率顯著低于低PLR值患者。PLR是判斷結直腸癌患者預後情況的重要指標,值得在臨床中運用。
목적:토론술전혈소판/림파세포비치(PLR)대결직장암환자예후적영향。방법:선취2007년6월-2012년6월본원수치적150례결직장암환자작위연구대상,근거수술전、후상규혈액검사결과,계산PLR。안조PLR시부<250,장환자분위고치조(PLR≥250)28례화저치조(PLR<250)122례。관찰비교량조환자적일반자료、불동TNM분기화불동분화정도적5년존활솔,이탐토PLR대결직장암환자예후적영향。결과:고치조결장암환자비례67.86%(19/28)명현고우저치조적45.90%(56/122),접수복강경수술비례14.29%(4/28)명현저우저치조적40.16%(49/122),저치조적5년생존솔77.05%(94/122)명현고우고치조적50.00%(14/28),차고치조만기환자(Ⅲ、Ⅳ기)화분화차환자(차급점액성환자)적5년생존솔분별위28.57%(4/14)화40.00%(4/10),균명현저우저치조적62.90%(39/62)화75.00%(27/36),차이균유통계학의의(P<0.05)。결론:고PLR치결직장암환자적5년존활솔현저저우저PLR치환자。PLR시판단결직장암환자예후정황적중요지표,치득재림상중운용。
Objective:To discuss the preoperative platelet/lymphocyte ratio(PLR)impact on the prognosis of patients with colorectal cancer.Method:150 patients with colorectal cancer from June 2007 to June 2012 in our hospital were selected as research objects.According to the results of routine blood tests before surgery ,calculating PLR.According to whether PLR<250,patients were divided into high-value group(PLR ≥ 250)for 22 cases and low-value group (PLR<250)for 122 cases.The clinical general information,five-year survival rate in different TNM stages and different degrees of differentiation of two groups were observed and compared.The effect of PLR on the prognosis of patients with colorectal cancer were investigated.Result:The proportion of colon cancer in high-value group was 67.86%(19/28),it was significantly higher than 45.90%(56/122)in low-value group,the proportion of undergoing laparoscopic surgery in high-value group was 14.29%(4/28),it was significantly lower than 40.16%(49/122)in low-value group,five-year survival rate of low-value group was 77.05%(94/122),it was significantly than 50.00%(14/28)of high-value group, The five-year survival rate of advanced cancer( Ⅲ, Ⅳstage)and differentiation of patients(patients with poor and mucinous)in high-value group were 28.57%(4/14)and 40.00%(4/10),they were significantly lower than 62.90%(39/62) and 75.00%(27/36)in low-value group,the differences were statistically significant(P<0.05).Conclusion:Five-year survival rate of high PLR value colorectal cancer patients is significantly lower than low PLR value patients.PLR is an important index to judge the prognosis of colorectal cancer patients,it is worth in clinical application..